Initial company report · November 10, 2026

AmeriHealth Caritas Findings

Florida workforce notice and the Next pharmacy benefit transition.

This initial report covers verified sources only. The 2020-forward historical review is incomplete; missing records do not indicate an absence of enforcement.

Recent company updates

New developments.

Workforce notice

Published 2026-10-29 · Added 2026-11-10

Event date: 2026-12-31

Florida WARN index lists 61 affected workers at AmeriHealth Caritas Orlando site

FloridaCommerce lists an October 29 notice affecting 61 workers at one Orlando location, with a planned period from December 31, 2026 through April 7, 2027. Added during follow-up on November 10.

Why it matters: The index establishes the reported plan and scope, not completed reductions or an impact on member care.

Planned action in state WARN index; underlying notice unavailable during review

FloridaCommerce WARN index: source

Amerihealth-Caritas findings

November 20 targeted review added CMS program-wide ACO results. Company and state coverage remains incomplete.

CMS and managed care news archive

Next pharmacy benefit transition

The October 1 provider notice says AmeriHealth Caritas Next and First Choice Next will move pharmacy claims, rebates and pharmacy network contracting from PerformRx to Optum Rx on January 1, 2027. AmeriHealth Caritas retains formulary oversight and prior authorization. The notice cautions that some pharmacy participation may change.

This announcement concerns the named Marketplace products. It does not verify a Medicaid procurement award, a contract value or completed implementation.

October 1 provider notice

Orlando workforce notice

FloridaCommerce lists 61 workers affected at one Orlando location in an October 29 WARN notice, with the planned period running from December 31, 2026 through April 7, 2027. The underlying notice did not load. Completion and effects on access to care remain unverified.

FloridaCommerce WARN index

Research gaps

State Medicaid contract records, enforcement and leadership history remain incomplete. Executive compensation for a privately held organization cannot be compared with public-company proxy figures without matching the entity, period and compensation definition.